drugset / Trial / NCT02832375

Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

NCT02832375

Phase 3 Completed 242 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This single center, comparative design study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use compared with a standard fluoride dentifrice.

Timeline

Start
2016-03-01
Primary completion
2016-05-01
Completion
2016-05-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium monofluorophosphate Unknown 0.76 %
Subject stannous fluoride Small molecule 0.454 % Topical

Indications